Blog
RSS FeedPosted by Michael Wonder on 06 Mar 2016
Public summary documents - PBAC November 2015 meeting
4 March 2016 - The public summary documents (recommendations and subsequent decisions not to recommend) from the November 2015 PBAC meeting ...
Posted by Michael Wonder on 06 Mar 2016
Public release documents - DUSC October 2015 meeting
4 March 2016 - The public release documents from the utilisation analyses considered at the October 2015 DUSC meeting are now ...
Posted by Michael Wonder on 04 Mar 2016
Post-market reviews of COPD medicines and ezetimibe – public consultation
4 March 2016 - The public submission process is now open for the Post-market Reviews of ezetimibe and medicines for COPD. The ...
Posted by Michael Wonder on 01 Mar 2016
Schedule of Pharmaceutical Benefits - 1 March 2016 update
1 March 2016 - The March 2016 issue of the Schedule sees the listing of four new treatment options for patients ...
Posted by Michael Wonder on 29 Feb 2016
Hep C cures now as cheap as $6.20
1 March 2016 - Breakthrough cheap hepatitis cures are now available to Australians, but many don't even know they have the ...
Posted by Michael Wonder on 24 Feb 2016
PBAC Guidelines review
24 February 2016 - A presentation forum will be held on 15 March 2016 in Sydney, enabling interested stakeholders the opportunity ...
Posted by Michael Wonder on 19 Feb 2016
Public Summary Document - PBAC July 2015 meeting
19 February 2016 - The Public Summary Document for nivolumab (Opdivo) is now available on the PBS website. ...
Posted by Michael Wonder on 19 Feb 2016
Pharmaceutical Benefit Advisory Committee Guidelines review
19 February 2016 - The draft revised PBAC Guidelines are now published on the PBS website. Interested stakeholders can provide views about ...
Posted by Michael Wonder on 03 Feb 2016
2016 April price disclosure cycle - indicative prices
3 February 2016 - Indicative 1 April 2016 prices resulting from the 2016 April cycle of price disclosure have now been ...
Posted by Michael Wonder on 31 Jan 2016
Schedule of Pharmaceutical Benefits - 1 February 2016 update
1 February 2016 - The February 2016 issue of the Schedule sees the listing of one new medicine (ruxolitinib phosphate) ...
Posted by Michael Wonder on 29 Jan 2016
PBS biosimilar awareness - updated implementation framework
29 January 2016 - As part of the PBS biosimilar awareness Initiative, the updated implementation framework is now available. ...
Posted by Michael Wonder on 27 Jan 2016
PBS Generic Medicines Working Group communiques
27 January 2016 - The communiques from the first two meetings of the Generic Medicines Working Group are now available on ...
Posted by Michael Wonder on 07 Jan 2016
Additional outcome from the November 2015 PBAC meeting
7 January 2016 - The PBAC decided not to recommend pirfenidone for PBS listing for idiopathic pulmonary fibrosis on the ...
Posted by Michael Wonder on 06 Jan 2016
PBAC rebukes Amgen for lodging early submission for Repatha under TGA-PBAC parallel process
6 January 2016 - The PBAC noted that the intent of the submission was to initiate a dialogue rather than ...
Posted by Michael Wonder on 04 Jan 2016
Expanded PBS Safety Net early supply arrangements apply from 1 January 2016
4 January 2016 - Measures announced as part of the PBS Access and Sustainability package include expanding Safety Net early supply ...